Loading company details...
Beta
Latest Form 4 (Oct 7, 2026): Jim Wassil (EVP, Chief Scientific Ofc, COO): Exercise/Conversion of 18,000 shares, $96.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Jim Wassil, EVP, Chief Scientific Ofc, COO | Exercise/Conversion | 18,000 | $96.3K |
| Oct 7, 2026 | Elvia Cowan, SVP, Finance & CAO | Exercise/Conversion | 19,000 | $492.5K |
| Oct 2, 2026 | Jim Wassil, EVP, Chief Scientific Ofc, COO | Exercise/Conversion | 2,250 | $12.0K |
| Sep 9, 2026 | Grant Pickering, CHIEF EXECUTIVE OFFICER | Tax Withholding | 17,056 | $1.03M |
| Sep 9, 2026 | Andrew Guggenhime, PRESIDENT AND CFO | Tax Withholding | 7,155 | $431.9K |
| Sep 9, 2026 | Harpreet S. Dhaliwal, Chief Technical Ops Officer | Tax Withholding | 7,651 | $461.8K |
| Sep 9, 2026 | Elvia Cowan, SVP, Finance & CAO | Tax Withholding | 1,327 | $80.1K |
| Sep 9, 2026 | Jim Wassil, EVP, Chief Scientific Ofc, COO | Sale | 1,381 | $84.5K |
| Sep 9, 2026 | Luis Jodar, Chief Medical Officer | Grant/Award | 52,632 | n/a |
| Sep 2, 2026 | Jim Wassil, CHIEF OPERATING OFFICER | Tax Withholding | 1,273 | $77.3K |